Use of Exhaled Nitric Oxide Levels to Tailor Asthma Medications in Children
This study enrolls children ages 5-17 with asthma. The purpose of this research study is to find out if a breathing test called FeNO changes how doctors decide to treat your asthma. The FeNO test measures the amount of nitric oxide in the air you slowly breath out of your lungs and is a test for inflammation in the lungs. The FeNO test can also help doctors determine how well your asthma medications are suppressing inflammation in the lungs.
We expect that your child will be in this research study for 30 minutes on a single visit. You will be asked to answer a few questions about your child’s asthma. Your child will also be asked to breathe slowly and steadily into a portable FeNO machine, which takes under 2 minutes. Study takes place at UBMD Pediatrics Allergy/Immunology clinic locations.
The aim of this study is to determine if measuring FeNO versus traditional guideline based management (symptoms and spirometry) alters asthma management decisions in regard to escalating or stepping down anti-inflammatory medications.
Compensation may include cash, checks, gift cards, debit cards, or incentives like gift baskets, technology items, or merchandise.
Children ages 5-17.
Diagnosis of asthma.
Patients of the UBMD Pediatrics Allergy/Immunology clinic.
Let us know how the study team can reach you.
If you do not hear back within 2 business days, reach out to the study team directly at the contact information above or email firstname.lastname@example.org and someone will assist you.